Edition:
United Kingdom

Amgen Says European Commission Approves Prolia For Patients With Glucocorticoid-Induced Osteoporosis


Friday, 8 Jun 2018 

June 8 (Reuters) - Amgen Inc ::EUROPEAN COMMISSION APPROVES PROLIA® (DENOSUMAB) FOR PATIENTS WITH GLUCOCORTICOID-INDUCED OSTEOPOROSIS.AMGEN - EC APPROVED NEW INDICATION FOR PROLIAFOR TREATMENT OF BONE LOSS ASSOCIATED WITH LONG-TERM SYSTEMIC GLUCOCORTICOID THERAPY.